BIO – bio-rad laboratories, inc. class a (US:NASDAQ)
Stock Stats
News
5/8
02:33 pm
bio
Low
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down [Yahoo! Finance]
5/8
10:09 am
bio
Low
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $420.00 to $385.00. They now have a "buy" rating on the stock.
5/7
04:15 pm
bio
Medium
Bio-Rad Reports First-Quarter 2024 Financial Results
5/7
04:13 am
bio
Low
Molecular Weight Marker Market Forecast Report 2019-2029, Featuring Bio-Rad Laboratories, Merck, New England Biolabs, Promega, QIAGEN, VWR, Takara Bio, HiMedia Laboratories and GeneDireX [Yahoo! Finance]
5/1
09:00 am
bio
Low
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
5/7/2024
04:15 pm
bio
-4.4%
BEAT
2/15/2024
04:15 pm
bio
3.6%
BEAT
10/26/2023
04:15 pm
bio
-7.2%
MISS
8/3/2023
04:15 pm
bio
-0.4%
BEAT
5/8
09:14 am
Maintains
Buy
Buy
UBS
Low
-1.1%
4/3
10:22 am
Maintains
Buy
Buy
Citigroup
Low
-0.6%
4/3
10:22 am
Maintains
Buy
Buy
Citigroup
Low
-0.6%
4/3
08:07 am
Downgrades
Buy
Neutral
Citigroup Inc.
Low
0.2%
4/3
05:56 am
Downgrades
NEUTRAL ON LIMITED VISIBILITY
CITI
Low
1.0%
5/9
04:31 pm
bio
Low
Form SD BIO-RAD LABORATORIES,
5/8
04:38 pm
bio
Medium
Form S-8 BIO-RAD LABORATORIES,
5/8
04:32 pm
bio
Medium
Form 10-Q BIO-RAD LABORATORIES, For: Mar 31
5/8
02:26 pm
bio
Low
Form 3 BIO-RAD LABORATORIES, For: May 01 Filed by: BARRY JAMES
5/7
04:19 pm
bio
Medium
Form 8-K BIO-RAD LABORATORIES, For: May 07
Show more
Top News Gainers
4/8 Biodesix Begins Coronavirus COVID-19 Testing 8.8%
3/12 Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing 8.7%
8/1 Form 8-K BIO-RAD LABORATORIES, For: Aug 01 8.3%
4/1 Form 3 BIO-RAD LABORATORIES, For: Apr 01 Filed by: RAMALINGAM AJIT 7.7%
2/13 Bio-Rad Reports Fourth-Quarter and Full-Year 2019 Financial Results 7.4%
10/31 Q3/2019 9/30/2019 EPS 1.610 ZacksConsensus 1.360 ActVsEst 0.250 - Beat 6.2%
5/8 Q1/2019 3/31/2019 EPS 1.650 ZacksConsensus 1.120 ActVsEst 0.530 - Beat 4.3%
3/2 Form 10-K BIO-RAD LABORATORIES, For: Dec 31 4.1%
12/13 Bio-Rad Makes Progress Recovering from Recent Ransomware Attack 3.5%
3/30 Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Wells Fargo & Co from $440.00 to $385.00. They now have an "overweight" rating on the stock. 3.4%
Top News Decliners
3/20 Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR™ Test to the U.S. -5.5%
8/2 Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.1%
5/10 Form 10-Q BIO-RAD LABORATORIES, For: Mar 31 -4.8%
12/9 Form 8-K BIO-RAD LABORATORIES, For: Dec 05 -4.4%
9/9 Form 4 BIO-RAD LABORATORIES, For: Sep 05 Filed by: TUMOLO ANNETTE -3.7%
3/18 Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing -3.4%
4/6 Form 8-K BIO-RAD LABORATORIES, For: Apr 01 -2.9%
4/9 Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider -2.4%
4/21 Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity -1.7%
9/20 Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -1.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3